Dr Kellia Chiu
People_

Dr Kellia Chiu

Associate Lecturer (Teaching and Research)
Sydney Pharmacy School
Faculty of Medicine and Health
Dr Kellia Chiu

Dr Kellia Chiu is an Associate Lecturer with the Sydney Pharmacy School. Prior to this, Kellia was a postdoctoral research fellow in Toronto, Canada with the Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, and with the Lunenfeld-Tanenbaum Research Institute, Sinai Health System.

Her PhD focused on exploring the development of policies affecting community pharmacy practice. She has conducted research in critical areas of health policy across both Australia and Canada, including the use and regulation of opioids for pain and substance use disorders; vaccination access through pharmacies; policy responses to the COVID-19 pandemic; and the expanding role of pharmacists in the healthcare system. Her research expertise is in health policy analysis, primarily using qualitative research involving documentary analyses, key informant interviews, and comparative approaches.

Kellia is also a registered pharmacist and has experience working as a pharmacist-in-charge at a local community pharmacy.

Kellia's research focuses on applying public policy analysis approaches to pharmacy practice research. In her doctoral research, she has examined the beliefs and values of policy actors within the pharmacy policy landscape; the influence of federalism structures on pharmacy practice in Australia; the nature and role of evidence in policymaking; and the impact of crises and the COVID-19 pandemic on changing professional scopes of practice.

In her postdoctoral research, she led and conducted a series of comparative policy analyses on opioid use disorder treatment in primary care through a health systems lens, compaing policies internationally, within Canadian provinces/territories, and between Canada and Australia. Her work has focused on understanding health systems and primary care systems may support or constrain care for people with substance use disorders, and its interaction with political contexts that influence drug policy (including treatment, harm reduction, and drug decriminalisation). She is also a co-investigator on three Canadian Institutes of Health Research Catalyst Grants that support this work.

In her role, she has initiated and developed partnerships with health policy researchers and with a range of research end users in Australia and Canada, including clinicians, people with lived/living experience of drug use, and individuals from advocacy organisations, knowledge translation organisations, and government health departments.

Building on these projects and partnerships, she aims to continue exploring policies affecting pharmacy practice, particularly policy agenda setting and design of pharmacist prescribing policies; the commercial influences and interactions in community pharmacy, including governance mechanisms; and federalism in immunisation policy.

  • Public health
  • Health policy analysis; qualitative approaches; comparative approaches
  • Pharmaceutical policy
  • Drug policy
  • Health professional practice policy

Publications

Journals

  • Chiu, K., Pandya, S., Sharma, M., Hooimeyer, A., De Souza, A., Sud, A. (2024). An international comparative policy analysis of opioid use disorder treatment in primary care across nine high-income jurisdictions. Health Policy, 141, 104993. [More Information]
  • Sud, A., Campbell, C., Sivakumar, A., Upshur, R., Moineddin, R., Chiu, K. (2024). Federal opioid agonist therapy policy: interrupted time series analysis of the impact of the methadone exemption removal across eight provinces in Canada. BMC Health Services Research, 24(1). [More Information]
  • Chiu, K., Thow, A., Bero, L. (2023). A comparative analysis of the roles and use of evidence in pharmacy policy in Australia. Evidence and Policy, 19(2), 217-235. [More Information]

2024

  • Chiu, K., Pandya, S., Sharma, M., Hooimeyer, A., De Souza, A., Sud, A. (2024). An international comparative policy analysis of opioid use disorder treatment in primary care across nine high-income jurisdictions. Health Policy, 141, 104993. [More Information]
  • Sud, A., Campbell, C., Sivakumar, A., Upshur, R., Moineddin, R., Chiu, K. (2024). Federal opioid agonist therapy policy: interrupted time series analysis of the impact of the methadone exemption removal across eight provinces in Canada. BMC Health Services Research, 24(1). [More Information]

2023

  • Chiu, K., Thow, A., Bero, L. (2023). A comparative analysis of the roles and use of evidence in pharmacy policy in Australia. Evidence and Policy, 19(2), 217-235. [More Information]
  • Chiu, K., Thow, A., Bero, L. (2023). Understanding the Dynamics of More Restrictive Medicines Policy: A Case Study of Codeine Up-Scheduling in Australia. International Journal of Health Policy and Management, 12(1). [More Information]

2022

  • Chiu, K., Thow, A., Bero, L. (2022). The tension between national consistency and jurisdictional professional expansion: The case of pharmacist-administered vaccinations. Research in Social and Administrative Pharmacy, 18(10), 3782-3791. [More Information]
  • Chiu, K., Thow, A., Bero, L. (2022). “Never waste a good crisis”: Opportunities and constraints from the COVID-19 pandemic on pharmacists’ scope of practice. Research in Social and Administrative Pharmacy, 18(9), 3638-3648. [More Information]

2021

  • Bero, L., Lawrence, R., Leslie, L., Chiu, K., McDonald, S., Page, M., Grundy, Q., Parker, L., Boughton, S., Kirkham, J., et al (2021). Cross-sectional study of preprints and final journal publications from COVID-19 studies: Discrepancies in results reporting and spin in interpretation. BMJ Open, 11(7), e051821. [More Information]

2020

  • Anglemyer, A., Moore, T., Parker, L., Chambers, T., Grady, A., Chiu, K., Parry, M., Wilczynska, M., Flemyng, E., Bero, L. (2020). Digital contact tracing technologies in epidemics: a rapid review. Cochrane Database of Systematic Reviews, 2020 (8), CD013699. [More Information]
  • Chiu, K., McDonald, S., Legg, T., Karanges, E., Bero, L. (2020). Policies affecting the supply and access of opioid analgesics: a scoping review protocol. JBI Evidence Synthesis, 18(5), 1124-1134. [More Information]

2019

  • Grundy, Q., Chiu, K., Bero, L. (2019). Commercialization of User Data by Developers of Medicines-Related Apps: a Content Analysis. Journal of General Internal Medicine, 34(12), 2833-2841. [More Information]
  • Grundy, Q., Chiu, K., Held, F., Continella, A., Bero, L., Holz, R. (2019). Data sharing practices of medicines related apps and the mobile ecosystem: Traffic, content, and network analysis. BMJ, 364, 1-11. [More Information]
  • Bero, L., Chiu, K., Grundy, Q. (2019). The SSSPIN study-spin in studies of spin: meta-research analysis. BMJ, 367, l6202. [More Information]

2017

  • Chiu, K., Grundy, Q., Bero, L. (2017). 'Spin' in published biomedical literature: A methodological systematic review. PLoS Biology, 15(9), 1-16. [More Information]